JANUARY 14, 2020
T R A C I N N O V A T I O N S P A R T O F T H E M O S T A D V A N C E D H O S P I T A L I N N O R T H E R N E U R O P E
Jan 14, 2020 the Queen of Denmark inaugurated Rigshospitalet’s new North Wing, the most advanced hospital in Northern Europe. We are very proud that our MRI Motion Tracker is part of their modern solution. As Prof. MD Gitte Moos Knudsen, Neurobiology Research Unit, mentions in the news, the equipment can profoundly improve MRI image quality because it can correct for blurring caused by head motion. Patients with e.g. dementia or movement disorders can be scanned and sedation of children can be reduced. Watch the news from Danish TV Avisen, January 14th 2020, here (starting 6:30 into the clip).
DECEMBER 18, 2019
M E E T T R A C I N N O V A T I O N S AT A R A B H E A L T H 2 0 2 0
TracInnovations will be at Arab Health 2020 in Dubai, UAE. Please meet us and learn more about our Markerless Motion Tracker for brain MRI scan. If you would like to book a meeting in advance – please click here.
NOVEMBER 15, 2019
M E E T T R A C I N N O V A T I O N S A T R S N A 2019
TracInnovations will be at Radiological Society of North America, RSNA 2019 in Chicago. Please meet us and learn more about our Markerless Motion Tracker for brain MRI scan. If you would like to book a meeting in advance – please click here.
SEPTEMBER 20, 2019
O P E N P O S I T I O N A T T R A C I N N O V A T I O N S
TracInnovations is currently looking for a talented software developer to join our growing software team. Please see more details here and send your application to us as soon as possible.
SEPTEMBER 17, 2019
N E W I N V E S T O R S
In addition to the investments secured earlier this year from Investo Capital and Syddansk Innovation, a complementary investment has been undertaken with a consortium of private investors from US and Denmark. These include Dale Flanders, David Hardwick and Jes Broeng, all of whom come with a strong entrepreneurial background in combination with a comprehensive experience from medical science and technology driven companies.
With our new co-owners, we have added significant competence and expertise to the company and look forward to the cooperation in regards to enhancing further our technology and product development as well as our market expansion.
– Dale Flanders
Dale is an entrepreneur and author of more than 100 issued US patents and a substantial amount of technical publications and a substantial experience from especially fiber optic communications. He was founder of Axsun Technologies, supplying advanced technology to telecom, medical and industrial applications. Axsun raised more than USD 150 million of investments (while Dale served as CEO) and was sold to Volcano Corp. (specializing in cardiovascular diagnostics) and later to Philips. Dale today is investor and advisor in several companies, including Danish Norlase and Faunaphotonics. Dale has a Ph.D. in Electrical and Electronics Engineering from MIT.
– David Hardwick
David has been a part of the photonics industry for over 40 years and has extensive experience as CEO, board representative and investor. He is especially experienced in transformative situations including licensing, M&A, company funding and exits. He was on the board of Swedish start-up Altitun AB (tunable laser technology for all-optical networks) when sold to ADC for USD 935m in year 2000. David today is investor, board member and Chair in several companies, including Danish Norlase and Faunaphotonics.
– Jes Broeng
Jes is professor and director at DTU Entrepreneurship. From a science background, he has co-founded a number of successful Danish startups, including Crystal Fibre (sold in 2008, now NKT Photonics), Norlase, Bifrost Communications, OSAA Innovation and OptoCeutics. He is a member of the Danish Academy of Technical Sciences and a Fellow of SPIE (the international society for optics and photonics). Jes has strong international relations to UC Berkeley and he leads a national university-industry program in entrepreneurship.
SEPTEMBER 10, 2019
S A L E S D I R E C T O R , C S O
We are happy to inform that we have employed Ian Lauritzen as our new Sales Director, CSO. Ian has a solid background from the MedTech Industry – including 20 years at Philips Healthcare. With Ian onboard we will expand our activities on the international MRI and PET market.
MAY 20, 2019
( C L O S E D ) O P E N P O S I T I O N A T T R A C I N N O V A T I O N S
TracInnovations is currently looking for a high-performing and experienced Sales Director, who will be crucial in commercializing the company, fulfilling our sales targets and penetrating the international MRI and PET market.
MAY 1, 2019
V I S I T T R A C I N N O V A T I O N S A T I S M R M
TracInnovations will be at ISMRM 2019 in Montreal. Please come by our booth #425 and learn more about our Markerless Motion Tracker. If you would like to book a meeting in advance, please click here.
APRIL 20, 2019
J O U R N A L P U B L I C A T I O N S
We are very proud of the great work that our research collaborations do. Recently, two articles based on our markerless motion tracker have been published in recognized international journals.
Robert Frost et al. published their work in Magnetic Resonance in Medicine about fast motion tracking and high‐frequency motion correction during imaging echo trains. Read more about their work here: “Markerless high‐frequency prospective motion correction for neuroanatomical MRI”
Jakob Slipsager et al. published an article in PLOS ONE, evaluating the first markerless motion tracker compatible with PET, MRI, and simultaneous PET/MRI systems for motion correction of brain imaging. Read more about their work here: “Markerless motion tracking and correction for PET, MRI, and simultaneous PET/MRI”
APRIL 12, 2019
P R E S S R E L E A S E
Investo Capital invests in medtech company TracInnovations
Investo Capital has entered into an investment agreement with TracInnovations, one of Denmark’s rising stars in the field of advanced medical technology. The investment will help TracInnovations further develop the company’s unique technology, which enables magnetic resonance imaging (MRI) scans of children and adults who struggle to lie still during the scan. This is expected to contribute to a reduction in the use of general anaesthetic during MRI scans as well as a significant reduction in the need for subsequent rescans.
Aalborg/Ballerup, 5 April 2019 – TracInnovations’ technology is based on many years of research by the company’s current co-owner and CTO, Oline Vinter Olesen, who has been working on the technology since 2006 at DTU and Rigshospitalet. TracInnovations was established as a company in 2015, after which things really began to take off. TracInnovations’ technology is already being used for research purposes at Rigshospitalet, Boston Children’s Hospital, Karolinska University Hospital and Cardiff University Brain Imaging Center, which is regarded as Europe’s leading MRI research institution. TracInnovations’ technology can be integrated with MRI scanners from GE, Philips and Siemens. Collectively, these three companies account for a significant share of the market.
TracInnovations’ technology helps MRI staff get more satisfactory MRI scan results. It is also expected that the technology can help make MRI scans an increasingly feasible option for patient groups that struggle to lie still. This is possible with the help of an advanced 3D surface scanner that shows whether a patient moves during the scan with pinpoint accuracy. If the scanner detects the patient has moved, the staff can immediately perform a new scan. This represents a quantum leap in the field because it helps avoid hospitals having to recall patients for a second scan, while also allowing clinics to reduce the number of rescans, the use of general anaesthetic on children and diagnostics based on blurred images. These are one of the reasons behind Investo Capitals’ decision to invest in TracInnovations, which has also previously received a significant injection from Syddansk Innovation (SDI), which invests venture capital in innovative ideas. SDI will also be providing additional funding in this round.
“It all began more than a decade ago, and since then I’ve had a strong focus on research, development and clinical verification of our Tracoline system. With our current team of six employees and external partners, we have achieved great results in collaboration with our clinical partner which can optimise the use of MRI scans internationally. The potential of TracInnovations’ technology is tremendous and can also find application in other areas such as CT and PET scans. Most importantly, we expect that in the long run, TracInnovations’ technology can help make a large portion of general anaesthesia administration for children – which should ideally be avoided – unnecessary,” said Oline Vinter Olesen, CTO of TracInnovations.
“We are looking into a global market, and our first hospital customers have confirmed that combining our technology with MRI scanners can ensure more accurate scans and thereby allow for more accurate diagnoses. It also allows hospitals to perform MRI scans on more patients, as we help optimise the scanning workflow. Today, 10-20% of patients are recalled for a rescan due to blurred images. With the new injection of capital, thanks to a new investment by Investo Capital together with Syddansk Innovation, we can now carry on with the positive development of our company and product,” said Kim Bendixen, CEO of TracInnovations.
Heartland and NOVI Innovation joined forces to found Investo Capital last year, as both parties believe there is a gap in the market for seed and early-stage investments in Danish startups. Investo Capital’s investment strategy focuses on companies with innovative technology and which have found their first customers and partners, putting them at a stage where they are ramping up commercialisation and product development. Not only does TracInnovations fit that profile, but the core values of TracInnovations and Investo Capital are very similar.
“We have followed TracInnovations’ development for some time now, and we are impressed with their pioneering technology and ability to establish partnerships with some of the most esteemed MRI scanning hospitals in the world. The market for MRI scanners in neurology is expected to grow by around six per cent a year, and the application of the technology is set to increase as it becomes more sophisticated and increasingly used for purposes such as earlier diagnosis. We are confident that the company has international development potential, which is why we will do our part to support its growth and contribute to creating an even stronger business,” said Thor Birkmand, Partner at Investo Capital.